• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION TOSOH HLC-723G8 ANALYZER G8 Back to Search Results
Model Number G8
Device Problem Detachment Of Device Component (1104)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/23/2016
Event Type  malfunction  
Manufacturer Narrative
A field service engineer (fse) was dispatched to address the reported event.On 24-feb-2016, fse arrived at the site to replace the peek tubing at the tube line filter.No further issues were reported and no further action was required from field service.The most probable cause of the reported event was due to broken peek tubing for the tube line filter.(b)(4).This report is being submitted due to a retrospective review conducted under capa-(b)(4).
 
Event Description
A customer in the (b)(6) contacted biomérieux to report a misidentification of actinomyces species in association with the vitek® ms system.Vitek ms obtained the following results for three tests: spot k2: single choice to streptococcus anginosus; spot k3: single choice to streptococcus constellatus; spot k4: single choice to actinomyces meyeri.Testing via alternate method (bruker) obtained actinomyces odontolyticus.Reference method testing (e.G.Sequencing) was not performed.The customer stated that the vitek ms results were not reported to the treating physician and had no impact on patient treatment decisions.There have been no adverse impact on patient health.Based on review of the mzml log files and calibration logs, preliminary analysis indicates the customer's slide spot preparation is non-optimal and heterogeneous; hence the inconsistent organism identifications.In addition, the fine-tuning of the instrument does not meet all specified criteria.Biomérieux investigation has been initiated to perform vitek ms instrument fine-tuning and provide additional spot preparation training for the customer.This will be followed by testing of the same specimen to monitor for consistency and accuracy of result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOSOH HLC-723G8 ANALYZER G8
Type of Device
G8
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo 10586 23
JA  1058623
Manufacturer (Section G)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo 10586 23
JA   1058623
Manufacturer Contact
doria esquivel
6000 shoreline court
suite 101
south san francisco, CA 94080
6506368123
MDR Report Key7329823
MDR Text Key102337716
Report Number8031673-2018-01970
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071132
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial
Report Date 03/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Device Catalogue Number021560
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA03/11/2018
Distributor Facility Aware Date02/23/2016
Device Age5 YR
Event Location Outpatient Diagnostic Facility
Date Report to Manufacturer03/11/2018
Initial Date Manufacturer Received 02/23/2018
Initial Date FDA Received03/11/2018
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/01/2011
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-